← Eichor
Study identifier: NCT07048340 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cognitive-behavioral Therapy for Insomnia in School-aged Children

Condition: Insomnia  ·  Sponsor: Tel Aviv University

PhaseNA
Planned participants120
Who can joinAll sexes, 7 Years to 11 Years
Healthy volunteersNo

About this study

This randomized controlled trial will test the efficacy of CBT-I intervention for school-aged children (7-11 years old) with insomnia. The trial will focus on the role of sleep restriction therapy in treatment. Children will be randomized to one of three groups: (1) CBT-I; (2) CBT-I without SRT; or (3) a waitlist control group. Assessments will occur at baseline, mid-treatment, post-treatment, and a 3-month follow up. Some measures (e.g., child motivation) will also be assessed after each therapy session. Insomnia and sleep-wake patterns will be assessed objectively using actigraphy, and subjectively using sleep diaries, a clinical diagnostic interview, and questionnaires. Parent and child questionnaires will be administered to assess moderators and mediators of treatment outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Michal Kahn, PhD  ·  +972544682588  ·  michalkahn10@gmail.com

Shai Nimrodi, MA  ·  058-426-6060  ·  shainimrodi@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tel Aviv UniversityTel Aviv, Israel, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07048340